Gene screening and prevention of hereditary breast cancer: a clinical view

被引:3
作者
Klijn, JGM [1 ]
Meijers-Heijboer, H
机构
[1] Dr Daniel Den Hoed Canc Ctr, Rotterdam Family Canc Clin, Dept Med Oncol, Rotterdam, Netherlands
[2] Erasmus Univ, Ctr Med, Rotterdam, Netherlands
来源
EJC SUPPLEMENTS | 2003年 / 1卷 / 01期
关键词
D O I
10.1016/S1359-6349(03)00005-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nowadays, the major tasks of the increasing number of family cancer clinics are to provide general information about cancer, to perform risk assessment, to offer (presymptomatic) DNA-testing, to advise on lifestyle, to take steps for early detection and prevention of cancer, for psychological support and to carry out research programmes by a multidisciplinary approach. In approximately 25-30%,, of the families with a hereditary pattern of breast cancer a germline mutation can be demonstrated, most commonly in the BRCA1 and BRCA2 genes. Mutations in these genes are associated with high life-time risks of breast and ovarian cancer. The introduction of MR1 increased the sensitivity for early detection of breast cancer in comparison with mammography. Thus far, prophylactic bilateral total mastectomy is the most effective and safest way of prevention but prophylactic oophorectomy and chemopreventionare reasonable alternatives. In particular young women with children make use of DNA-testing and surgical prevention. By a shared decision-making process, the patient and her medical doctor have to make the right choice of management policy based on her individual circumstances. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 104 条
[1]   THE WOMAN AT INCREASED RISK FOR BREAST-CANCER - EVALUATION AND MANAGEMENT STRATEGIES [J].
BILIMORIA, MM ;
MORROW, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 1995, 45 (05) :263-278
[2]   Patient regrets after bilateral prophylactic mastectomy [J].
Borgen, PI ;
Hill, ADK ;
Tran, KN ;
Van Zee, KJ ;
Massie, MJ ;
Payne, D ;
Biggs, CG .
ANNALS OF SURGICAL ONCOLOGY, 1998, 5 (07) :603-606
[3]  
Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310
[4]   Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk [J].
Brekelmans, CTM ;
Seynaeve, C ;
Bartels, CCM ;
Tilanus-Linthorst, MMA ;
Meijers-Heijboer, EJ ;
Crepin, CMG ;
van Geel, AN ;
Menke, M ;
Verhoog, LC ;
van den Ouweland, A ;
Obdeijn, IM ;
Klijn, JGM .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) :924-930
[5]   Recommendations for follow-up care of individuals with an inherited predisposition to cancer .2. BRCA1 and BRCA2 [J].
Burke, W ;
Daly, M ;
Garber, J ;
Botkin, J ;
Kahn, MJE ;
Lynch, P ;
McTierman, A ;
Offit, K ;
Perlman, J ;
Petersen, G ;
Thomson, E ;
Varricchio, C .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (12) :997-1003
[6]   Clinical management of women with genomic BRCA1 and BRCA2 mutations [J].
Chang, J ;
Elledge, RM .
BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (02) :101-113
[7]   The influence of familial and hereditary factors on the prognosis of breast cancer [J].
Chappuis, PO ;
Rosenblatt, J ;
Foulkes, WD .
ANNALS OF ONCOLOGY, 1999, 10 (10) :1163-1170
[8]   Primary care: Reducing the risk of breast cancer [J].
Chlebowski, RT .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (03) :191-198
[9]  
Claus EB, 1996, CANCER, V77, P2318, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2318::AID-CNCR21>3.0.CO
[10]  
2-Z